Stock 688198 BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Beijing Balance Medical Technology Co.,Ltd.

Equities

688198

CNE100005X15

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
107.9 CNY -0.89% Intraday chart for Beijing Balance Medical Technology Co.,Ltd. -3.42% -13.36%
Apr. 22 Beijing Balance Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 28 Balance Medical Technology's Profit Jumps 21% in 2023 MT

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 91.43 times its estimated earnings per share for the ongoing year.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-13.36% 2.03B - -
STRYKER CORPORATION Stock Stryker Corporation
+16.65% 133B
A-
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-3.76% 11.52B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-4.86% 8.3B
C
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-22.44% 4.69B
C
AXONICS, INC. Stock Axonics, Inc.
+7.79% 3.42B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-17.26% 2.54B
B-
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-16.39% 1.86B -
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-31.24% 1.59B
C-
MEDARTIS HOLDING AG Stock Medartis Holding AG
-8.10% 1.17B
B-
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
-
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. 688198 Stock
  4. Ratings Beijing Balance Medical Technology Co.,Ltd.